Skip to content

Genetic identification and determination of pathogenic bacteria of diabetic foot ulcer infection Discussion on quantitative analysis method

Genetic identification and determination of pathogenic bacteria of diabetic foot ulcer infection Discussion on quantitative analysis method

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400094248
Enrollment
Unknown
Registered
2024-12-19
Start date
2025-01-01
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic foot ulcer

Interventions

Experimental group:The infected wound of the patients foot ulcer was collected

Sponsors

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Patients diagnosed with diabetic foot infection with an infected wound; 2.Age >=18 years old, male or female; 3.It can provide sufficient infected wound samples (>=5mm^3 infected wound tissue samples or >=100µL infected wound secretions) and can be used for detection and analysis of gene chips; 4.No history of antibiotic therapy prior to sampling (within 4 weeks) or known failure to respond to antibiotic therapy (failure to respond to >=2 antibiotics); 5.Fully understand the nature, significance, possible benefits, possible inconveniences or potential risks of this research; Understand the study procedure, participate voluntarily and be willing to complete the entire study process, and sign the informed consent;

Exclusion criteria

Exclusion criteria: 1.Patients with undiagnosed diabetic foot infection; 2.Patients who had received antibiotics within 4 weeks prior to sampling; 3.Complicated with serious systemic disease (e.g., malignant tumor, severe cardiopulmonary insufficiency, etc.); 4.Pregnant or lactating women; 5.Cognitive impairment or inability to cooperate with the research process; 6.History of allergies or allergies to materials related to the study;

Design outcomes

Primary

MeasureTime frame
Sensitivity;positive predictive value;negative predictive value;specificity;

Secondary

MeasureTime frame
Cure rate;Recurrence rate;

Countries

China

Contacts

Public ContactWeiqing Wang

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

wwq10320@rjh.com.cn+86 21 54661789

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026